tiprankstipranks
Celldex Therapeutics (CLDX)
NASDAQ:CLDX
US Market
CLDX
Celldex
RESEARCH TOOLSreports
Want to see CLDX full AI Analyst Report?

Celldex (CLDX) Ratios

1,258 Followers

Celldex Ratios

CLDX's free cash flow for Q1 2026 was $-55.93. For the 2026 fiscal year, CLDX's free cash flow was decreased by $ and operating cash flow was $-5.63K. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 8.92 10.49 18.91 13.87 17.07
Quick Ratio
 8.92 10.49 18.91 13.87 17.07
Cash Ratio
 0.69 0.57 0.72 1.12 1.58
Solvency Ratio
 -5.09 -4.58 -3.41 -3.80 -4.12
Operating Cash Flow Ratio
 -4.32 -4.14 -3.99 -3.45 -5.57
Short-Term Operating Cash Flow Coverage
 -151.65 -135.92 0.00 0.00 0.00
Net Current Asset Value
$ 404.19M$ 478.85M$ 701.82M$ 395.24M$ 291.16M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
 <0.01 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.12 1.11 1.06 1.08 1.08
Debt Service Coverage Ratio
 -204.71 -164.57 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 0.03 0.04 0.06 0.05 0.09
Net Debt to EBITDA
 0.11 0.10 0.13 0.23 0.24
Profitability Margins
Gross Profit Margin
-4.15%100.00%-2229.77%-1614.53%-3389.94%
EBIT Margin
-36984.02%-17253.33%-2778.89%-2063.66%-4543.74%
EBITDA Margin
-36573.41%-17028.00%-2733.63%-2019.96%-4420.87%
Operating Profit Margin
-37694.63%-19160.00%-2778.89%-2245.27%-4889.01%
Pretax Profit Margin
-34596.22%-17253.33%-2248.76%-2054.76%-4765.59%
Net Profit Margin
-34596.22%-17253.33%-2248.76%-2054.76%-4765.59%
Continuous Operations Profit Margin
-34596.22%-17253.33%-2248.76%-2054.76%-4765.59%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
91.78%90.05%80.92%91.51%97.48%
Return on Assets (ROA)
-55.49%-44.39%-19.92%-30.37%-31.84%
Return on Equity (ROE)
-50.72%-49.09%-21.13%-32.95%-34.43%
Return on Capital Employed (ROCE)
-67.23%-54.02%-25.91%-35.57%-34.49%
Return on Invested Capital (ROIC)
-67.01%-53.87%-25.86%-35.44%-34.34%
Return on Tangible Assets
-58.61%-46.56%-20.63%-32.26%-34.50%
Earnings Yield
-13.79%-14.33%-9.70%-7.36%-5.37%
Efficiency Ratios
Receivables Turnover
 3.57 0.74 10.03 1.52 6.79
Payables Turnover
 0.08 0.00 50.09 33.78 24.63
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.09 0.19 0.85 1.04 0.30
Asset Turnover
 <0.01 <0.01 <0.01 0.01 <0.01
Working Capital Turnover Ratio
 <0.01 <0.01 0.01 0.02 <0.01
Cash Conversion Cycle
 -4.33K 490.32 29.11 229.31 38.92
Days of Sales Outstanding
 102.38 490.32 36.40 240.12 53.74
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 4.43K 0.00 7.29 10.81 14.82
Operating Cycle
 102.38 490.32 36.40 240.12 53.74
Cash Flow Ratios
Operating Cash Flow Per Share
 -3.34 -3.17 -2.45 -2.21 -2.21
Free Cash Flow Per Share
 -3.39 -3.21 -2.48 -2.25 -2.25
CapEx Per Share
 0.06 0.04 0.03 0.04 0.04
Free Cash Flow to Operating Cash Flow
 1.02 1.01 1.01 1.02 1.02
Dividend Paid and CapEx Coverage Ratio
 -58.46 -77.72 -82.22 -59.02 -56.75
Capital Expenditure Coverage Ratio
 -58.46 -77.72 -82.22 -59.02 -56.75
Operating Cash Flow Coverage Ratio
 -116.44 -90.30 -41.38 -42.21 -25.72
Operating Cash Flow to Sales Ratio
 -270.93 -140.63 -22.48 -15.59 -44.01
Free Cash Flow Yield
-10.99%-11.83%-9.81%-5.68%-5.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -7.25 -6.98 -10.31 -13.59 -18.60
Price-to-Sales (P/S) Ratio
 2.51K 1.20K 231.80 279.16 886.63
Price-to-Book (P/B) Ratio
 4.51 3.43 2.18 4.48 6.41
Price-to-Free Cash Flow (P/FCF) Ratio
 -9.10 -8.45 -10.19 -17.61 -19.80
Price-to-Operating Cash Flow Ratio
 -9.26 -8.56 -10.31 -17.91 -20.15
Price-to-Earnings Growth (PEG) Ratio
 0.18 -0.12 0.64 -0.63 -0.40
Price-to-Fair Value
 4.51 3.43 2.18 4.48 6.41
Enterprise Value Multiple
 -6.74 -6.97 -8.35 -13.59 -19.81
Enterprise Value
 2.02B 1.78B 1.60B 1.89B 2.06B
EV to EBITDA
 -6.74 -6.97 -8.35 -13.59 -19.81
EV to Sales
 2.47K 1.19K 228.31 274.48 875.86
EV to Free Cash Flow
 -8.95 -8.33 -10.04 -17.31 -19.56
EV to Operating Cash Flow
 -9.10 -8.44 -10.16 -17.61 -19.90
Tangible Book Value Per Share
 6.45 7.52 11.18 8.30 6.38
Shareholders’ Equity Per Share
 6.85 7.93 11.60 8.86 6.96
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.01 0.02 0.11 0.14 0.05
Net Income Per Share
 -4.26 -3.89 -2.45 -2.92 -2.40
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.94 1.00 0.81 1.00 1.05
Research & Development to Revenue
 323.76 163.40 23.30 17.15 34.90
SG&A to Revenue
 54.18 29.20 5.49 4.49 11.54
Stock-Based Compensation to Revenue
 43.20 24.14 4.88 3.47 0.00
Income Quality
 0.78 0.82 1.00 0.76 0.92
Currency in USD